These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3381709)
1. Alternaria allergy: a three-year controlled study in children treated with immunotherapy. Cantani A; Businco E; Maglio A Allergol Immunopathol (Madr); 1988; 16(1):1-4. PubMed ID: 3381709 [TBL] [Abstract][Full Text] [Related]
2. A three year controlled study in children with pollinosis treated with immunotherapy. Cantani A; Businco E; Benincori N; de Angelis M; di Fazio A; Businco L Ann Allergy; 1984 Jul; 53(1):79-84. PubMed ID: 6377983 [TBL] [Abstract][Full Text] [Related]
3. [Allergy caused by Alternaria in children]. Angrisano A; Di Berardino L; Montrasio G; Compostella G Pediatr Med Chir; 1987; 9(2):159-60. PubMed ID: 3658799 [TBL] [Abstract][Full Text] [Related]
4. [Respiratory sensitization to molds in children: myth or reality?]. Guerrier G; Billard E; Ghipponi J; Gillioz F; Noiret A; Payot F; Pujol MT; Robert J; Springer G Allerg Immunol (Paris); 1989 Nov; 21(9):333-7. PubMed ID: 2624678 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of alternaria alternata allergy: a prospective study in 6840 Italian asthmatic children. Cantani A; Ciaschi V Eur Rev Med Pharmacol Sci; 2004; 8(6):289-94. PubMed ID: 15745389 [TBL] [Abstract][Full Text] [Related]
7. Influence of IgG antibody and glycopeptide allergens on the correlation between the radioallergosorbent test (RAST) and skin testing or bronchial challenge with alternaria. Lynch NR; Dunand P; Newcomb RW; Chai H; Bigley J Clin Exp Immunol; 1975 Oct; 22(1):35-46. PubMed ID: 765019 [TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of various methods of diagnosing hypersensitivity to Alternaria. Escudero AI; Sánchez-Guerrero IM; Mora AM; Soriano V; López JD; García FJ; Negro JM; Hernández J; Pagán JA Allergol Immunopathol (Madr); 1993; 21(4):153-7. PubMed ID: 8237720 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children. Kuna P; Kaczmarek J; Kupczyk M J Allergy Clin Immunol; 2011 Feb; 127(2):502-508.e1-6. PubMed ID: 21281874 [TBL] [Abstract][Full Text] [Related]
10. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. Horst M; Hejjaoui A; Horst V; Michel FB; Bousquet J J Allergy Clin Immunol; 1990 Feb; 85(2):460-72. PubMed ID: 2406323 [TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety. Tabar AI; Lizaso MT; García BE; Gómez B; Echechipía S; Aldunate MT; Madariaga B; Martínez A Pediatr Allergy Immunol; 2008 Feb; 19(1):67-75. PubMed ID: 17651380 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of efficacy of immunotherapy in children with asthma monosensitized to Alternaria. Kiliç M; Altintaş DU; Yilmaz M; Bingöl-Karakoç G; Burgut R; Güneşer-Kendirli S Turk J Pediatr; 2011; 53(3):285-94. PubMed ID: 21980810 [TBL] [Abstract][Full Text] [Related]
13. [Immunotherapy with an oral Alternaria extract in childhood asthma. Clinical safety and efficacy and effects on in vivo and in vitro parameters]. Criado Molina A; Guerra Pasadas F; Daza Muñoz JC; Moreno Aguilar C; Almeda Llamas E; Muñoz Gomariz E; Font Ugalde P; Alonso Díaz C; Germán Cárdenas M; Sánchez Guijo P Allergol Immunopathol (Madr); 2002; 30(6):319-30. PubMed ID: 12464165 [TBL] [Abstract][Full Text] [Related]
14. Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years. Rienzo VD; Minelli M; Musarra A; Sambugaro R; Pecora S; Canonica WG; Passalacqua G Clin Exp Allergy; 2005 May; 35(5):560-4. PubMed ID: 15898975 [TBL] [Abstract][Full Text] [Related]
16. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma. Tabar AI; Lizaso MT; García BE; Echechipía S; Olaguibel JM; Rodríguez A J Investig Allergol Clin Immunol; 2000; 10(6):327-33. PubMed ID: 11206932 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy]. Ibáñez Sendín MD Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375 [TBL] [Abstract][Full Text] [Related]
18. Allergy to Alternaria. II. Diagnostic comparison of skin-tests and RAST. Valencia M; Randazzo L; Tapias G; Granel C; Olivé A Allergol Immunopathol (Madr); 1993; 21(2):84-7. PubMed ID: 8337993 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Ozdemir C; Yazi D; Gocmen I; Yesil O; Aydogan M; Semic-Jusufagic A; Bahceciler NN; Barlan IB Pediatr Allergy Immunol; 2007 Sep; 18(6):508-15. PubMed ID: 17680909 [TBL] [Abstract][Full Text] [Related]
20. Studies on Alternaria allergens. V. Comparative biochemical and immunological studies of three isolates of Alternaria tenuis cultured on synthetic media. Vijay HM; Young NM; Jackson GE; White GP; Bernstein IL Int Arch Allergy Appl Immunol; 1985; 78(1):37-42. PubMed ID: 3928499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]